Available online 2 January 2023, 100748

Find the most suitable prediction model method: feature selection-deep learning.

Select the strong survival correlation feature set from Clinical dataset.

FTD system predicts the median survival time of patients at different stages.

GA optimized DNN to improve the model accuracy of esophageal cancer.

GA-DNN is successfully applied to a non-image continuous dataset.

Esophageal cancer is a high occult malignant tumor. Even with good diagnosis and treatment, the 5-year survival rate of esophageal cancer patients is still less than 30%. Considering the influence of clinical characteristics on postoperative esophageal cancer patients, the construction of a neural network model will help improve the poor prognosis of patients in the five years.

In this study, genetic algorithm optimized deep neural network is exploited to the clinical dataset of esophageal cancer. The independent prognostic factors are screened by Relief algorithm and Cox proportional risk regression. FTD prognostic staging system is established to assess the risk level of esophageal cancer patients.

FTD staging system and independent prognostic factors are integrated into the genetic algorithm optimized deep neural network. The Area Under Curve (AUC) of FTD staging system is 0.802. FTD staging system is verified by the Kaplan-Meier survival curve, and the median survival time is divided for different risk grades. The FTD staging system is superior to the TNM stages in the prognosis effect. The AUC of deep neural network optimized by genetic algorithm is 0.91.

The deep neural network optimized by genetic algorithm has good performance in predicting the 5-year survival status of esophageal cancer patients. The FTD staging system has a significant prognostic effect. The FTD staging system and genetic algorithm optimized deep neural network can be successfully availed in clinical diagnosis and treatment.

Genetic algorithm

Deep Neural Network

Esophageal cancer

Relief algorithm

Cox proportional risk regression analysis

© 2022 AGBM. Published by Elsevier Masson SAS. All rights reserved.